$CLNE
Clean Energy Fuels Corp.

2024 Q2 Form 10-Q Financial Statement

#000155837024007619 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $97.95M $103.7M
YoY Change 8.18% -21.54%
Cost Of Revenue $63.94M $75.60M
YoY Change -0.35% -40.6%
Gross Profit $34.01M $28.11M
YoY Change 28.91% 471.88%
Gross Profit Margin 34.72% 27.1%
Selling, General & Admin $28.34M $26.24M
YoY Change -0.72% -11.51%
% of Gross Profit 83.32% 93.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.26M $11.18M
YoY Change 3.41% 4.72%
% of Gross Profit 33.12% 39.78%
Operating Expenses $28.34M $26.24M
YoY Change -0.72% -11.51%
Operating Profit -$5.592M -$9.311M
YoY Change -57.17% -73.71%
Interest Expense -$10.08M -$9.581M
YoY Change 186.77% 171.65%
% of Operating Profit
Other Income/Expense, Net -$40.00K $98.00K
YoY Change -242.86% 127.91%
Pretax Income -$15.71M -$18.79M
YoY Change -5.03% -51.68%
Income Tax $800.0K -$178.0K
% Of Pretax Income
Net Earnings -$16.29M -$18.44M
YoY Change -0.05% -52.34%
Net Earnings / Revenue -16.63% -17.78%
Basic Earnings Per Share -$0.07 -$0.08
Diluted Earnings Per Share -$0.07 -$0.08
COMMON SHARES
Basic Shares Outstanding 223.3M 223.2M
Diluted Shares Outstanding 223.3M 223.2M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $249.3M $248.9M
YoY Change 30.04% 13.17%
Cash & Equivalents $123.1M $89.39M
Short-Term Investments $126.2M $159.5M
Other Short-Term Assets $26.66M $33.24M
YoY Change -46.21% -28.22%
Inventory $49.41M $48.98M
Prepaid Expenses
Receivables $92.11M $85.48M
Other Receivables $25.04M $21.82M
Total Short-Term Assets $450.9M $448.9M
YoY Change 14.92% 1.68%
LONG-TERM ASSETS
Property, Plant & Equipment $440.0M $426.2M
YoY Change 23.74% 27.33%
Goodwill $64.33M $64.33M
YoY Change 0.0% 0.0%
Intangibles $6.365M $6.365M
YoY Change 0.0% 0.0%
Long-Term Investments $250.3M $254.0M
YoY Change 27.18% 32.28%
Other Assets
YoY Change
Total Long-Term Assets $795.4M $787.2M
YoY Change 21.62% 25.33%
TOTAL ASSETS
Total Short-Term Assets $450.9M $448.9M
Total Long-Term Assets $795.4M $787.2M
Total Assets $1.246B $1.236B
YoY Change 19.1% 15.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.84M $41.83M
YoY Change -10.81% 6.87%
Accrued Expenses $91.16M $83.67M
YoY Change 18.99% -14.22%
Deferred Revenue $7.794M $7.787M
YoY Change 134.12% 78.76%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $43.00K $42.00K
YoY Change 13.16% 13.51%
Total Short-Term Liabilities $142.4M $143.1M
YoY Change 11.0% -5.72%
LONG-TERM LIABILITIES
Long-Term Debt $262.9M $261.9M
YoY Change 81.52% 80.79%
Other Long-Term Liabilities $12.87M $12.65M
YoY Change 44.47% 31.09%
Total Long-Term Liabilities $275.8M $274.6M
YoY Change 79.38% 77.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.4M $143.1M
Total Long-Term Liabilities $275.8M $274.6M
Total Liabilities $516.7M $506.5M
YoY Change 50.43% 38.45%
SHAREHOLDERS EQUITY
Retained Earnings -$964.2M -$947.9M
YoY Change 8.95% 9.12%
Common Stock $1.691B $1.674B
YoY Change 6.87% 6.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $723.0M $722.9M
YoY Change
Total Liabilities & Shareholders Equity $1.246B $1.236B
YoY Change 19.1% 15.57%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$16.29M -$18.44M
YoY Change -0.05% -52.34%
Depreciation, Depletion And Amortization $11.26M $11.18M
YoY Change 3.41% 4.72%
Cash From Operating Activities $18.77M $2.590M
YoY Change 55.83% -113.63%
INVESTING ACTIVITIES
Capital Expenditures $17.39M $18.21M
YoY Change -41.86% 2.42%
Acquisitions
YoY Change
Other Investing Activities $33.32M -$834.0K
YoY Change -135.97% -101.07%
Cash From Investing Activities $15.93M -$19.85M
YoY Change -113.0% -132.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -972.0K 1.832M
YoY Change -31.55% -337.31%
NET CHANGE
Cash From Operating Activities 18.77M 2.590M
Cash From Investing Activities 15.93M -19.85M
Cash From Financing Activities -972.0K 1.832M
Net Change In Cash 33.72M -15.55M
YoY Change -130.13% -138.06%
FREE CASH FLOW
Cash From Operating Activities $18.77M $2.590M
Capital Expenditures $17.39M $18.21M
Free Cash Flow $1.375M -$15.62M
YoY Change -107.7% -57.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222717113
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223210309
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001368265
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
223026966
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2024Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2024Q1 us-gaap Fair Value Asset Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1 us-gaap Fair Value Asset Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2024Q1 us-gaap Fair Value Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1 us-gaap Fair Value Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
223263055
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-33480
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
CLEAN ENERGY FUELS CORP.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0968580
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4675 MacArthur Court
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Newport Beach
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92660
CY2024Q1 dei City Area Code
CityAreaCode
949
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
437-1000
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
CLNE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
223263055
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106963000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91412000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
158186000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
159486000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1475000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1536000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
98426000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85478000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
19770000
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
21817000
CY2023Q4 us-gaap Inventory Net
InventoryNet
45335000
CY2024Q1 us-gaap Inventory Net
InventoryNet
48977000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41495000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41736000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
470175000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
448906000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
92324000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
90408000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
331758000
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
335772000
CY2023Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
35735000
CY2024Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
36405000
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
258773000
CY2024Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
253953000
CY2023Q4 us-gaap Goodwill
Goodwill
64328000
CY2024Q1 us-gaap Goodwill
Goodwill
64328000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6365000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6365000
CY2023Q4 us-gaap Assets
Assets
1259458000
CY2024Q1 us-gaap Assets
Assets
1236137000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
38000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1758000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1948000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6687000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6923000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
56995000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
41833000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
91534000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
83672000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4936000
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7787000
CY2023Q4 clne Derivative Liability Current Related Party
DerivativeLiabilityCurrentRelatedParty
1875000
CY2024Q1 clne Derivative Liability Current Related Party
DerivativeLiabilityCurrentRelatedParty
877000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
163823000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
143082000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
261123000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
261926000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1839000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1368000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
89065000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87498000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9961000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12654000
CY2023Q4 us-gaap Liabilities
Liabilities
525811000
CY2024Q1 us-gaap Liabilities
Liabilities
506528000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
454000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
454000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
223026966
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
223263055
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
22000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
22000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1658339000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1673792000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-929472000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-947915000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2119000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2994000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
726770000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
722905000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
6877000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
6704000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
733647000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
729609000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1259458000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1236137000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132183000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103709000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29649000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26237000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10678000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11182000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
167595000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
113020000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-35412000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9311000
CY2023Q1 clne Interest Expense Nonoperating
InterestExpenseNonoperating
4354000
CY2024Q1 clne Interest Expense Nonoperating
InterestExpenseNonoperating
7762000
CY2023Q1 clne Interest Income Nonoperating
InterestIncomeNonoperating
2717000
CY2024Q1 clne Interest Income Nonoperating
InterestIncomeNonoperating
3579000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
98000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1890000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5398000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38896000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18794000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-64000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-178000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-18616000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-135000
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-173000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-38697000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-18443000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222717113
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223210309
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-18616000
CY2023Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsTax
0
CY2024Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsTax
0
CY2023Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsNetOfTax
461000
CY2024Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsNetOfTax
-809000
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
244000
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-66000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-875000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-38127000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19491000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
727471000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
332000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
175000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6096000
CY2023Q1 clne Apic Share Based Payment Arrangement Increase For Sales Incentive Charges
ApicShareBasedPaymentArrangementIncreaseForSalesIncentiveCharges
8172000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
703769000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-18616000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10678000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11182000
CY2023Q1 clne Provision For Doubtful Accounts Notes And Inventory
ProvisionForDoubtfulAccountsNotesAndInventory
502000
CY2024Q1 clne Provision For Doubtful Accounts Notes And Inventory
ProvisionForDoubtfulAccountsNotesAndInventory
274000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6096000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2629000
CY2023Q1 clne Contra Revenue From Contract With Customer Excluding Assessed Tax
ContraRevenueFromContractWithCustomerExcludingAssessedTax
13730000
CY2024Q1 clne Contra Revenue From Contract With Customer Excluding Assessed Tax
ContraRevenueFromContractWithCustomerExcludingAssessedTax
12897000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2532000
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1622000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-1213000
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-948000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
49000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-64000
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
333000
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1890000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5398000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1402000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2178000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-86000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-201000
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
76000
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
81000
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
19704000
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-12574000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2626000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3965000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1040000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
735000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1105000
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1593000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-606000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11744000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
129000
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2832000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6809000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8095000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19004000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2590000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49393000
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
158306000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
135500000
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
159072000
CY2023Q1 clne Payment Of Deposit On Property And Equipment
PaymentOfDepositOnPropertyAndEquipment
10147000
CY2024Q1 clne Payment Of Deposit On Property And Equipment
PaymentOfDepositOnPropertyAndEquipment
808000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17777000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18208000
CY2023Q1 clne Grant Proceeds For Capital Projects
GrantProceedsForCapitalProjects
1947000
CY2024Q1 clne Grant Proceeds For Capital Projects
GrantProceedsForCapitalProjects
652000
CY2023Q1 clne Proceeds Received For Joint Development And Construction Of Station Projects
ProceedsReceivedForJointDevelopmentAndConstructionOfStationProjects
0
CY2024Q1 clne Proceeds Received For Joint Development And Construction Of Station Projects
ProceedsReceivedForJointDevelopmentAndConstructionOfStationProjects
663000
CY2023Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
1140000
CY2024Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
3500000
CY2023Q1 clne Proceeds From Collection And Sale Of Loans Receivable
ProceedsFromCollectionAndSaleOfLoansReceivable
1483000
CY2024Q1 clne Proceeds From Collection And Sale Of Loans Receivable
ProceedsFromCollectionAndSaleOfLoansReceivable
253000
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0
CY2024Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
314000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
49000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60522000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19850000
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
332000
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
36000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
175000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
304000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
369000
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
575000
CY2023Q1 us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
100000
CY2024Q1 us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
3390000
CY2023Q1 clne Repayments Of Proceeds From Adopt Port Program Partnership Contribution
RepaymentsOfProceedsFromAdoptPortProgramPartnershipContribution
343000
CY2024Q1 clne Repayments Of Proceeds From Adopt Port Program Partnership Contribution
RepaymentsOfProceedsFromAdoptPortProgramPartnershipContribution
381000
CY2023Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
317000
CY2024Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
334000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-772000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1832000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-123000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40857000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15551000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125950000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106963000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166807000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91412000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13000
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
138000
CY2024Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
661000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
4106000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
6472000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying condensed consolidated financial statements and these notes. Actual results could differ from those estimates and may result in material effects on the Company’s operating results and financial position. Significant estimates made in preparing the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">accompanying condensed consolidated financial statements include (but are not limited to) those related to revenue recognition, fair value measurements, goodwill and long-lived asset valuations and impairment assessments, income tax valuations, stock-based compensation expense and stock-based sales incentive charges.</p>
CY2024Q1 clne Goodwill No Impairment Facts And Circumstances Leading To No Impairment
GoodwillNoImpairmentFactsAndCircumstancesLeadingToNoImpairment
The results of the quantitative goodwill impairment test performed as of March 31, 2024 indicated that the fair value of the Company’s reporting unit exceeded its carrying value by 7% or $70.0 million
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132183000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103709000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24300000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
98426000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85478000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7823000
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8501000
CY2023Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
2433000
CY2024Q1 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
2304000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10256000
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10805000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4936000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7787000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
151000
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
132000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5087000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7919000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1300000
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000
CY2024Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
8000000.0
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104944000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89393000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106963000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91412000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106963000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91412000
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
105600000
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
90100000
CY2024Q1 us-gaap Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
2000000.0
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
158158000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
28000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
158186000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
159472000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
159486000
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
19770000
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
21817000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
45335000
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
48977000
CY2023Q4 us-gaap Inventory Net
InventoryNet
45335000
CY2024Q1 us-gaap Inventory Net
InventoryNet
48977000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
823898000
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
838529000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
492140000
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
502757000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
331758000
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
335772000
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
36800000
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
37100000
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
34000000.0
CY2024Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
34500000
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
400000
CY2024Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
500000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10200000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6900000
CY2023Q4 clne Accrued Alternative Fuel Incentives Current
AccruedAlternativeFuelIncentivesCurrent
41609000
CY2024Q1 clne Accrued Alternative Fuel Incentives Current
AccruedAlternativeFuelIncentivesCurrent
33891000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
5315000
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3856000
CY2023Q4 clne Accrued Gas And Equipment Purchase Current
AccruedGasAndEquipmentPurchaseCurrent
17485000
CY2024Q1 clne Accrued Gas And Equipment Purchase Current
AccruedGasAndEquipmentPurchaseCurrent
21558000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1451000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1610000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4502000
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4073000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8697000
CY2024Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4988000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12475000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13696000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
91534000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
83672000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
300255000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
39094000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
261161000
CY2023Q4 clne Long Term Debt Gross Current Maturities
LongTermDebtGrossCurrentMaturities
38000
CY2023Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
38000
CY2023Q4 clne Long Term Debt Gross Excluding Current Maturities
LongTermDebtGrossExcludingCurrentMaturities
300217000
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
39094000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
261123000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
300231000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
38263000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
261968000
CY2024Q1 clne Long Term Debt Gross Current Maturities
LongTermDebtGrossCurrentMaturities
42000
CY2024Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2024Q1 clne Long Term Debt Gross Excluding Current Maturities
LongTermDebtGrossExcludingCurrentMaturities
300189000
CY2024Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
38263000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
261926000
CY2023Q4 clne Maximum Percentage Of Interest That Company May Elect To Pay In Kind
MaximumPercentageOfInterestThatCompanyMayElectToPayInKind
0.75
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-38697000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-18443000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222717113
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223210309
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222717113
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223210309
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77171311
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101174872
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2024Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6096000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2629000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
19700000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3800000
CY2021Q2 clne Shares Authorized
SharesAuthorized
304000000
CY2021Q2 clne Shares Authorized
SharesAuthorized
454000000
CY2024Q1 clne Shares Authorized
SharesAuthorized
455000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
454000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000.0
clne Stock Repurchase Program Repurchased Amount
StockRepurchaseProgramRepurchasedAmount
23500000
clne Stock Repurchase Program Total Stock Repurchased
StockRepurchaseProgramTotalStockRepurchased
9387340
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
26500000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
CY2024Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1300000
CY2023Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
100000
CY2024Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
100000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
721000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
962000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
985000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
1105000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
515000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
703000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
4991000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
1004000
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
3987000
CY2022Q1 clne Alternative Fuels Excise Tax Credit Compressed Natural Gas
AlternativeFuelsExciseTaxCreditCompressedNaturalGas
0.50
CY2022Q1 clne Alternative Fuels Excise Tax Credit Liquefied Natural Gas
AlternativeFuelsExciseTaxCreditLiquefiedNaturalGas
0.50
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-007619-index-headers.html Edgar Link pending
0001558370-24-007619-index.html Edgar Link pending
0001558370-24-007619.txt Edgar Link pending
0001558370-24-007619-xbrl.zip Edgar Link pending
clne-20240331.xsd Edgar Link pending
clne-20240331x10q.htm Edgar Link pending
clne-20240331xex31d1.htm Edgar Link pending
clne-20240331xex31d2.htm Edgar Link pending
clne-20240331xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
clne-20240331_lab.xml Edgar Link unprocessable
clne-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clne-20240331x10q_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clne-20240331_cal.xml Edgar Link unprocessable
clne-20240331_def.xml Edgar Link unprocessable